Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
TScan Therapeutics, Inc. Financials Banner

TScan Therapeutics, Inc. Financials

TCRX Stock Analysis

Page title

Section title

TCRX Income Statement Key Metrics

  • Revenue(TTM)12.20 M
  • Gross Profit(TTM)7.26 M
  • EBITDA(TTM)-110.31 M
  • Net Income(TTM)-104.41 M
  • EPS Diluted(TTM)-1.05

Decode TCRX's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

TCRX earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of TCRX (0.745) is higher than the average of its peers (0.372).

Net Profit Margin vs Peers

Net profit margin ratio of TCRX (-4.239) is lower than the average of its peers (-1.545).

TCRX Return on Equity

See how efficiently TCRX generates profit for it's shareholders.

-59.14%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of TCRX (-0.591) is higher than the average of its peers (-0.845).

Return on Equity Growth

TCRX's Return on Equity has shown poor growth over the past 10 years, increasing by only 5.01%.

TCRX Revenue Growth

See how TCRX has grown it's revenue over the past 10 years.


Revenue Growth

TCRX's revenue has grown significantly over the past 10 years, increasing by over 0%.

TCRX FY, 2023 Revenue Breakdown

See how TCRX converts it's revenue into profit.

TCRX Balance Sheet Health

TCRX Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

TCRX financial position analysis

Short Term Liabilities

TCRX's short term assets($194M) can safely cover it's short term liabilities($30M).

Long Term Liabilities

TCRX's short term assets($194M) can safely cover it's long term liabilities($91M).

TCRX Debt to Equity